Delayed enhancement of subendocardial infarcted myocardium with gadobenate dimeglumine: A paradoxical effect - Is a double dose too much? [3]

Radiology

Volumn 240, Issue 3, 2006, Pages 914-915

  Sardanelli, Francesco ^a   Quarenghi, Matteo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE; PLASMA PROTEIN;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOSE CALCULATION; DOSE RESPONSE; HEART INFARCTION; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL DETECTION; TIME;

CONTRAST MEDIA; ENDOCARDIUM; HUMANS; IMAGE ENHANCEMENT; MEGLUMINE; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; TIME FACTORS;

EID: 33747619179     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2403051674     Document Type: Letter

References (12)

1. Schlosser T, Hunold P, Herborn CU, et al. Myocardial infarct: depiction with contrast-enhanced MR imaging-comparison of gadopentetate and gadobenate. Radiology 2005;236:1041-1046.
2. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796.
3. Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 1998;33:798-809.
4. Knopp MV, Runge VM, Essig M, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2004;230:55-64.
5. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17:694-702.
6. Pediconi F, Catalano C, Occhiato R, et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 2005;237:45-56.
7. Schneider G, Maas R, Shultze Kool L, et al. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual cross-over comparison. Invest Radiol 2003;38:85-94.
8. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001;220:484-488.
9. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005;234:399-408.
10. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 2005;235:791-797.
11. Huber A, Schonberg SO, Spannagl B, Rieber J, Klauss V, Reiser MF. Determining myocardial viability in myocardial infarct: comparison of single and multislice MRI techniques with TurboFlash and TrueFISP sequences [in German]. Radiologe 2004;44:146-151.
12. Schneider G, Saedi D, Massmann A, et al. MultiHance in cardiac magnetic resonance imaging. Eur Radiol 2004;14(suppl 7):O71-O79.